{"rows":[{"id":6046,"title":"Furthering the Understanding of Psilocybin Use and Molecules Relevant to Depression and Schizophrenia.","authors":"Kalin NH.","journal":"The American journal of psychiatry","publication_date":"2026-11-01","publication_year":2026,"doi":"10.1176/appi.ajp.20260960","pubmed_id":"42966738","openalex_id":null,"source_url":"https://doi.org/10.1176/appi.ajp.20260960","substance_tags":"psilocybin","topic_tags":"Depression","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-11-02 02:20:04","last_checked":"2026-11-02 02:20:36","bibtex":null,"source_record_id":"PMID:42966738","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42966738","source_url":"https://doi.org/10.1176/appi.ajp.20260960","doi":"10.1176/appi.ajp.20260960","pmid":"42966738","publication_date":"2026-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":6045,"title":"Psilocybin Use in Psychiatry: Clinical Practice and Public Health Implications.","authors":"Olfson M.","journal":"The American journal of psychiatry","publication_date":"2026-11-01","publication_year":2026,"doi":"10.1176/appi.ajp.20260628","pubmed_id":"42966740","openalex_id":null,"source_url":"https://doi.org/10.1176/appi.ajp.20260628","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-11-02 02:20:04","last_checked":"2026-11-02 02:20:36","bibtex":null,"source_record_id":"PMID:42966740","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42966740","source_url":"https://doi.org/10.1176/appi.ajp.20260628","doi":"10.1176/appi.ajp.20260628","pmid":"42966740","publication_date":"2026-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":6044,"title":"The 'Civilising' of Psychedelics: Pharmaceuticalisation from Below as a Part-Process of American and European Informalisation","authors":"Michael Dunning, Jason Hughes, Hannah R. Farrimond, Joshua Stuart-Bennett","journal":"Human Figurations","publication_date":"2026-10-30","publication_year":2026,"doi":"10.29311/hf.v10i1.5449","pubmed_id":null,"openalex_id":"https://openalex.org/W7224883687","source_url":"https://doi.org/10.29311/hf.v10i1.5449","substance_tags":"psilocybin","topic_tags":"Addiction,Consciousness,Emotional Processing","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-11-01 02:20:24","last_checked":"2026-11-02 02:20:40","bibtex":null,"source_record_id":"DOI:10.29311/hf.v10i1.5449","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.29311/hf.v10i1.5449","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.29311/hf.v10i1.5449","source_url":"https://doi.org/10.29311/hf.v10i1.5449","doi":"10.29311/hf.v10i1.5449","pmid":"","publication_date":"2026-10-30","importer_version":"2.1.3","text_redistributed":false}},{"id":6043,"title":"The role of music therapy in psychedelic treatment: The case for safe, supported sound","authors":"Megan M. Druckrey","journal":"Journal of Psychedelic Studies","publication_date":"2026-10-30","publication_year":2026,"doi":"10.1556/2054.2026.00542","pubmed_id":null,"openalex_id":"https://openalex.org/W7224768967","source_url":"https://doi.org/10.1556/2054.2026.00542","substance_tags":"psilocybin","topic_tags":"Emotional Processing,Safety","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-11-01 02:20:24","last_checked":"2026-11-02 02:20:40","bibtex":null,"source_record_id":"DOI:10.1556/2054.2026.00542","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1556/2054.2026.00542","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2026.00542","source_url":"https://doi.org/10.1556/2054.2026.00542","doi":"10.1556/2054.2026.00542","pmid":"","publication_date":"2026-10-30","importer_version":"2.1.3","text_redistributed":false}},{"id":6042,"title":"Psychedelics and Psychedelic-Inspired Compounds for Substance Use Disorders: Are We Treating the Disease or Opening a Learning Window?","authors":"Adela Georgiana Buciuc, Mark S. Gold, Brian Fuehrlein","journal":"Brain Sciences","publication_date":"2026-10-29","publication_year":2026,"doi":"10.3390/brainsci16111184","pubmed_id":null,"openalex_id":"https://openalex.org/W7224416942","source_url":"https://doi.org/10.3390/brainsci16111184","substance_tags":"psilocybin","topic_tags":"Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Review Article,Safety,Toxicity","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-10-31 02:20:21","last_checked":"2026-11-02 02:20:40","bibtex":null,"source_record_id":"DOI:10.3390/brainsci16111184","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3390/brainsci16111184","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3390/brainsci16111184","source_url":"https://doi.org/10.3390/brainsci16111184","doi":"10.3390/brainsci16111184","pmid":"","publication_date":"2026-10-29","importer_version":"2.1.3","text_redistributed":false}},{"id":6041,"title":"The Fireside Database: Large-scale evidence from 25,419 psychedelic support interactions.","authors":"Schoeller F, Santolini M, Xiadani D, Eskinazi M, Murali A, Esselman D, Houtz W, Bellanca W, White J.","journal":"Science advances","publication_date":"2026-10-30","publication_year":2026,"doi":"10.1126/sciadv.aeg4737","pubmed_id":"42962007","openalex_id":"https://openalex.org/W7203593971","source_url":"https://doi.org/10.1126/sciadv.aeg4737","substance_tags":"psilocybin","topic_tags":"Observational Study,Drug Interactions","study_type":"Observational Study","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-31 02:20:05","last_checked":"2026-11-02 02:20:40","bibtex":null,"source_record_id":"PMID:42962007","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1126/sciadv.aeg4737","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42962007","source_url":"https://doi.org/10.1126/sciadv.aeg4737","doi":"10.1126/sciadv.aeg4737","pmid":"42962007","publication_date":"2026-10-30","importer_version":"2.1.3","text_redistributed":false}},{"id":6040,"title":"Quantum Chemical Topology and Energetic Analysis of Psychedelic and Non-Psychedelic Ligands in Coordination-Sphere Models of the Human 5-HT2A Receptor","authors":"Flores A, Lazcano-Carrasco IL, Lozano-Espinosa M, Soriano-Agueda L, Gómez-Castro CZ, Franco-Pérez M.","journal":"Research Square","publication_date":"2026-10-28","publication_year":2026,"doi":"10.21203/rs.3.rs-11502694/v1","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.21203/rs.3.rs-11502694/v1","substance_tags":"psilocin","topic_tags":"Receptor Pharmacology,Drug Interactions","study_type":"Other","source_name":"Europe PMC","publication_status":"preprint","date_added":"2026-10-30 02:20:18","last_checked":"2026-11-02 02:20:36","bibtex":null,"source_record_id":"DOI:10.21203/rs.3.rs-11502694/v1","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.21203/rs.3.rs-11502694/v1","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-11502694/v1","source_url":"https://doi.org/10.21203/rs.3.rs-11502694/v1","doi":"10.21203/rs.3.rs-11502694/v1","pmid":"","publication_date":"2026-10-28","importer_version":"2.1.3","text_redistributed":false}},{"id":6039,"title":"Psilocybin, cognitive stability and drinking reduction in co-occurring alcohol use disorder and depression: a pilot secondary analysis of a randomized, placebo-controlled trial","authors":"Sayali, C.; Weisman, E.; Barrett, F. S.","journal":"medRxiv","publication_date":"2026-10-29","publication_year":2026,"doi":"10.64898/2026.10.27.26366630","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.10.27.26366630","substance_tags":"psilocybin","topic_tags":"Depression,Addiction","study_type":"Clinical Trial","source_name":"medRxiv","publication_status":"preprint","date_added":"2026-10-30 02:20:18","last_checked":"2026-11-02 02:20:59","bibtex":null,"source_record_id":"DOI:10.64898/2026.10.27.26366630","abstract_available":true,"abstract_source":"medRxiv","abstract_source_url":"https://doi.org/10.64898/2026.10.27.26366630","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"medRxiv","source_record_id":"DOI:10.64898/2026.10.27.26366630","source_url":"https://doi.org/10.64898/2026.10.27.26366630","doi":"10.64898/2026.10.27.26366630","pmid":"","publication_date":"2026-10-29","importer_version":"2.1.3","text_redistributed":false}},{"id":6038,"title":"Multi-scale effects of single-dose psilocybin in the macaque brain","authors":"Wang J, Chen J, Sun W, Yang Z, Luo C, Yang F, Zhu Y, Wang H, Zhang X, Masthay J, Baek S, Li J, Zhuo Y, Wang X, Wu Y, Ma Y, Sun Q, Ji W, Chang S, Wang X, Zhu X, Hu J, Chen Y, Yuan T.","journal":"Research Square","publication_date":"2026-10-29","publication_year":2026,"doi":"10.21203/rs.3.rs-11081511/v1","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.21203/rs.3.rs-11081511/v1","substance_tags":"psilocybin","topic_tags":"Depression,Neuroplasticity,Pharmacology,Mechanism of Action,Mitochondrial Function,Proteomics,Metabolomics,Inflammation,Immune Function","study_type":"Other","source_name":"Europe PMC","publication_status":"preprint","date_added":"2026-10-30 02:20:18","last_checked":"2026-11-02 02:20:35","bibtex":null,"source_record_id":"DOI:10.21203/rs.3.rs-11081511/v1","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.21203/rs.3.rs-11081511/v1","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-11081511/v1","source_url":"https://doi.org/10.21203/rs.3.rs-11081511/v1","doi":"10.21203/rs.3.rs-11081511/v1","pmid":"","publication_date":"2026-10-29","importer_version":"2.1.3","text_redistributed":false}},{"id":6037,"title":"Psychedelic assisted psychotherapy (2020-2025): a scoping review of clinical evidence, mechanisms, safety, and ethics","authors":"Nasiru Mohammed Abdullahi, Rashid Menhas, Patience Osose Nasir, Mohamed Goda Elbqry, Fatma Mohamed Elmansy, Saddam Ahmed Al-Ahdal, Ashwaq Hamad Ali Alshmirry, Azza Elsayed Abd Elfatah Arafat, Samia Eaid Elgazzar, Fatima Sayed Osman Ashmieg","journal":"Frontiers in Psychology","publication_date":"2026-10-27","publication_year":2026,"doi":"10.3389/fpsyg.2026.1820860","pubmed_id":null,"openalex_id":"https://openalex.org/W7223781966","source_url":"https://doi.org/10.3389/fpsyg.2026.1820860","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Mechanism of Action,Consciousness,Spirituality,Clinical Trial,Randomized Controlled Trial,Review Article,Safety","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-10-29 02:20:17","last_checked":"2026-11-02 02:20:40","bibtex":null,"source_record_id":"DOI:10.3389/fpsyg.2026.1820860","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fpsyg.2026.1820860","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3389/fpsyg.2026.1820860","source_url":"https://doi.org/10.3389/fpsyg.2026.1820860","doi":"10.3389/fpsyg.2026.1820860","pmid":"","publication_date":"2026-10-27","importer_version":"2.1.3","text_redistributed":false}},{"id":6036,"title":"Connectedness as a candidate pathway linking psilocybin retreat experiences to sustained wellbeing: a prospective naturalistic study","authors":"Åkesson Maria, Granqvist Pehr, Johansson Robert, Gruneau Brulin Joel","journal":"Frontiers in Psychiatry","publication_date":"2026-10-28","publication_year":2026,"doi":"10.3389/fpsyt.2026.1924069","pubmed_id":null,"openalex_id":"https://openalex.org/W7224118297","source_url":"https://doi.org/10.3389/fpsyt.2026.1924069","substance_tags":"psilocybin","topic_tags":"Anxiety,Mechanism of Action,Wellbeing,Spirituality,Mystical Experience,Observational Study","study_type":"Observational Study","source_name":"Crossref","publication_status":"published","date_added":"2026-10-29 02:20:13","last_checked":"2026-11-02 02:20:40","bibtex":null,"source_record_id":"DOI:10.3389/fpsyt.2026.1924069","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3389/fpsyt.2026.1924069","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3389/fpsyt.2026.1924069","source_url":"https://doi.org/10.3389/fpsyt.2026.1924069","doi":"10.3389/fpsyt.2026.1924069","pmid":"","publication_date":"2026-10-28","importer_version":"2.1.3","text_redistributed":false}},{"id":6035,"title":"High-Quality Genome Assembly and Transcriptomic Analysis Reveal Potential Pathways for Psilocybin Biosynthesis in Gymnopilus dilepis","authors":"Yao Sen, Liu Yuanyuan, Xia Weiwei, Xia Yue, Yang Kai, Li Hui, Xie Baogui","journal":"Journal of Fungi","publication_date":"2026-10-28","publication_year":2026,"doi":"10.3390/jof12110811","pubmed_id":null,"openalex_id":"https://openalex.org/W7224137409","source_url":"https://doi.org/10.3390/jof12110811","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Pharmacology,Mechanism of Action,Genomics,Transcriptomics","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-10-29 02:20:12","last_checked":"2026-11-02 02:20:40","bibtex":null,"source_record_id":"DOI:10.3390/jof12110811","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3390/jof12110811","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3390/jof12110811","source_url":"https://doi.org/10.3390/jof12110811","doi":"10.3390/jof12110811","pmid":"","publication_date":"2026-10-28","importer_version":"2.1.3","text_redistributed":false}},{"id":6034,"title":"Psychedelics and psychosis: A systematic review of recent-era studies (1984-2025).","authors":"Reis JAS, Ueta LZ, Bouso JC, Hallak JEC, Dos Santos RG.","journal":"Journal of psychopharmacology (Oxford, England)","publication_date":"2026-10-27","publication_year":2026,"doi":"10.1177/02698811261488575","pubmed_id":"42937077","openalex_id":null,"source_url":"https://doi.org/10.1177/02698811261488575","substance_tags":"psilocybin","topic_tags":"Systematic Review,Review Article,Case Report,Healthcare Workers,Safety","study_type":"Systematic Review","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-28 02:20:05","last_checked":"2026-11-02 02:20:36","bibtex":null,"source_record_id":"PMID:42937077","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1177/02698811261488575","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42937077","source_url":"https://doi.org/10.1177/02698811261488575","doi":"10.1177/02698811261488575","pmid":"42937077","publication_date":"2026-10-27","importer_version":"2.1.3","text_redistributed":false}},{"id":6033,"title":"Magic pathways: the genes and enzymes of psilocybin biosynthesis.","authors":"Worbs J, Schäfer T, Seibold PS, Blei F, Werten S, Rupp B, Hoffmeister D.","journal":"Microbiology and molecular biology reviews: MMBR","publication_date":"2026-10-27","publication_year":2026,"doi":"10.1128/mmbr.00117-25","pubmed_id":"42937360","openalex_id":null,"source_url":"https://doi.org/10.1128/mmbr.00117-25","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,Mechanism of Action,Clinical Trial,Review Article,In Vitro Study","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-28 02:20:05","last_checked":"2026-11-02 02:20:35","bibtex":null,"source_record_id":"PMID:42937360","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1128/mmbr.00117-25","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42937360","source_url":"https://doi.org/10.1128/mmbr.00117-25","doi":"10.1128/mmbr.00117-25","pmid":"42937360","publication_date":"2026-10-27","importer_version":"2.1.3","text_redistributed":false}},{"id":6032,"title":"Safety, Efficacy, and Mechanisms of Psilocybin-assisted Acceptance and Commitment Therapy (PACT) in Treating Major Depressive Disorder (MDD) Among Veterans","authors":"VA Office of Research and Development","journal":"ClinicalTrials.gov","publication_date":"2026-10-26","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07895134","substance_tags":"psilocybin","topic_tags":"Depression,Neuroplasticity,Mechanism of Action,Psychological Flexibility,Clinical Trial,Randomized Controlled Trial,Veterans,Safety","study_type":"Randomized Controlled Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-10-27 02:22:54","last_checked":"2026-11-02 02:23:42","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07895134","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07895134","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07895134","source_url":"https://clinicaltrials.gov/study/NCT07895134","doi":"","pmid":"","publication_date":"2026-10-26","importer_version":"2.1.3","text_redistributed":false}},{"id":6031,"title":"Substantial Treatment-Seeking Interest, Narrow Eligibility: Diagnostic Heterogeneity and External Validity in the PRIDE Psilocybin Trial-Relevance to Precision Psychiatry","authors":"Inserra Antonio, Persico Luca, Rosati Arianna, Fabale Mara, Cavallotto Clara, D’Andrea Giacomo, Zoratto Francesca, Pettorruso Mauro, De Risio Luisa, Ventriglio Antonio, Bellomo Antonello, Nicolò Giuseppe, Martinotti Giovanni","journal":"Behavioral Sciences","publication_date":"2026-10-26","publication_year":2026,"doi":"10.3390/bs16111997","pubmed_id":null,"openalex_id":"https://openalex.org/W7223690592","source_url":"https://doi.org/10.3390/bs16111997","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Clinical Trial,Treatment-Resistant Depression","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-10-27 02:20:16","last_checked":"2026-11-02 02:20:40","bibtex":null,"source_record_id":"DOI:10.3390/bs16111997","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3390/bs16111997","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3390/bs16111997","source_url":"https://doi.org/10.3390/bs16111997","doi":"10.3390/bs16111997","pmid":"","publication_date":"2026-10-26","importer_version":"2.1.3","text_redistributed":false}},{"id":6030,"title":"Single Intranasal Administration of the Psychedelic Mebufotenin for Treatment-Resistant Depression: A Randomized Clinical Trial.","authors":"Feifel D, Seynaeve M, Cubala WJ, Dunbar F, Gründer G, Dueñas Herrero RM, Hindocha C, Liknaitzky P, McGuigan SM, Mehta S, Pierce M, Repantis D, Roberts C, Wiegand F, Conley R.","journal":"JAMA","publication_date":"2026-10-26","publication_year":2026,"doi":"10.1001/jama.2026.18380","pubmed_id":"42931733","openalex_id":"https://openalex.org/W7223694799","source_url":"https://doi.org/10.1001/jama.2026.18380","substance_tags":"psilocybin","topic_tags":"Depression,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-27 02:20:04","last_checked":"2026-11-02 02:20:40","bibtex":null,"source_record_id":"PMID:42931733","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1001/jama.2026.18380","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42931733","source_url":"https://doi.org/10.1001/jama.2026.18380","doi":"10.1001/jama.2026.18380","pmid":"42931733","publication_date":"2026-10-26","importer_version":"2.1.3","text_redistributed":false}},{"id":6029,"title":"Sex-related differences in outcomes following psilocybin or escitalopram: a Bayesian secondary analysis.","authors":"Frick A, Blest-Hopley G, Girn M, Erritzoe D, Nutt D, Carhart-Harris R.","journal":"Psychopharmacology","publication_date":"2026-10-26","publication_year":2026,"doi":"10.1007/s00213-026-07177-7","pubmed_id":"42931904","openalex_id":"https://openalex.org/W7223692295","source_url":"https://doi.org/10.1007/s00213-026-07177-7","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Wellbeing,Clinical Trial,Randomized Controlled Trial,Drug Interactions","study_type":"Randomized Controlled Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-27 02:20:04","last_checked":"2026-11-02 02:20:40","bibtex":null,"source_record_id":"PMID:42931904","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1007/s00213-026-07177-7","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42931904","source_url":"https://doi.org/10.1007/s00213-026-07177-7","doi":"10.1007/s00213-026-07177-7","pmid":"42931904","publication_date":"2026-10-26","importer_version":"2.1.3","text_redistributed":false}},{"id":6028,"title":"Direct Quantitation of Psilocybin and Psilocin by 1H and 31P qNMR in Wild Psilocybe from Greece","authors":"Dadiotis E, Antonopoulos R, Cheilari A, Kortsinoglou A, Melliou E, Mitsis V, Ioannidis K, Thankappan B, Delgoda R, Gonou-Zagou Z, Magiatis P.","journal":"ACS omega","publication_date":"2026-10-24","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC13689107","substance_tags":"psilocybin,psilocin","topic_tags":"General","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-26 02:20:18","last_checked":"2026-10-26 02:20:18","bibtex":null,"source_record_id":"https://europepmc.org/article/PMC/PMC13689107","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC13689107","source_url":"https://europepmc.org/article/PMC/PMC13689107","doi":"","pmid":"","publication_date":"2026-10-24","importer_version":"2.1.3","text_redistributed":false}},{"id":6027,"title":"Psilocybin and Clinical Depression","authors":"Richard Kensinger","journal":null,"publication_date":"2026-10-23","publication_year":2026,"doi":"10.13140/rg.2.2.36134.89921","pubmed_id":null,"openalex_id":"https://openalex.org/W7223284694","source_url":"https://doi.org/10.13140/rg.2.2.36134.89921","substance_tags":"psilocybin","topic_tags":"Depression,Spirituality","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-10-25 02:20:27","last_checked":"2026-10-30 02:20:22","bibtex":null,"source_record_id":"DOI:10.13140/rg.2.2.36134.89921","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.13140/rg.2.2.36134.89921","source_url":"https://doi.org/10.13140/rg.2.2.36134.89921","doi":"10.13140/rg.2.2.36134.89921","pmid":"","publication_date":"2026-10-23","importer_version":"2.1.3","text_redistributed":false}}],"total":5141,"page":1,"per_page":20,"pages":258,"resource":"papers","filters":{"notification":null,"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}